2007•Journal of Thoracic OncologyOpen access

Evaluation of the Recommended Dose and Efficacy of Amrubicin as Second- and Third-Line Chemotherapy for Small Cell Lung Cancer

Satoshi Igawa, Nobuyuki Yamamoto, Shinya Ueda, Akira Ono, Yukiko Nakamura, Asuka Tsuya, Haruyasu Murakami, Masahiro Endo, Toshiaki Takahashi

Open full text 36 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

Open-access reader

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 36 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Medicine, Neutropenia, Febrile neutropenia, Chemotherapy, Regimen, Lung cancer, Internal medicine, Chemotherapy regimen

Back to paper search Browse research topics Original source

Evaluation of the Recommended Dose and Efficacy of Amrubicin as Second- and Third-Line Chemotherapy for Small Cell Lung Cancer — Research Paper | ScholarLens